As for expression in tumors, VRK1 has been detected to be highly expressed in a variety of cancers, such as head and neck squamous cell carcinomas (HNSCC), and lung cancers especially with p53 mutations[21, 22]. Here, TP53 is linked to head and neck squamous cell carcinoma.